|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents including restricted cash | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit loss reserve, $21 and $10 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Note receivable, net of allowance for credit loss reserve, $12 and $0 as of December 31, 2025 and December 31, 2024, respectively | ||||||||||||||||||||
| Note receivable, net of allowance for credit loss reserve, $0 and $12 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Unbilled revenue | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||||
| PROPERTY AND EQUIPMENT, NET | ||||||||||||||||||||
| RIGHT OF USE ASSET | ||||||||||||||||||||
| INTANGIBLE ASSETS, NET | ||||||||||||||||||||
| GOODWILL | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Term note, current | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Other accrued expense | ||||||||||||||||||||
| Lease liability- current | ||||||||||||||||||||
| Contingent liability- current | ||||||||||||||||||||
| Contingent liability-current | ||||||||||||||||||||
| Convertible note – related party, current | ||||||||||||||||||||
| Convertible note, current | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| Contingent liability, non-current | ||||||||||||||||||||
| Long-term lease liability | ||||||||||||||||||||
| Term note | ||||||||||||||||||||
| Convertible note – related party | ||||||||||||||||||||
| Convertible note | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Common stock, $0.001 par value; 675,000,000 shares authorized; 13,626,076 and 13,553,049 shares issued, 13,165,196 and 13,071,601 shares outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Treasury stock at cost; 460,880 and 481,448 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
Loading...